The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection.
AuthorShoudy, Lauren E
Bowling, Jennifer D
Barry, Eileen M
Hazlett, Allan J
Hazlett, Brian A
Cooper, Kristine L
Pittman, Phillip R
Reed, Douglas S
Hazlett, Karsten R O
JournalPathogens (Basel, Switzerland)
MetadataShow full item record
AbstractIdentifying correlates of protection (COPs) for vaccines against lethal human (Hu) pathogens, such as Francisella tularensis (Ft), is problematic, as clinical trials are currently untenable and the relevance of various animal models can be controversial. Previously, Hu trials with the live vaccine strain (LVS) demonstrated ~80% vaccine efficacy against low dose (~50 CFU) challenge; however, protection deteriorated with higher challenge doses (~2000 CFU of SchuS4) and no COPs were established. Here, we describe our efforts to develop clinically relevant, humoral COPs applicable to high-dose, aerosol challenge with S4. First, our serosurvey of LVS-vaccinated Hu and animals revealed that rabbits (Rbs), but not rodents, recapitulate the Hu O-Ag dependent Ab response to Ft. Next, we assayed Rbs immunized with distinct S4-based vaccine candidates (S4ΔclpB, S4ΔguaBA, and S4ΔaroD) and found that, across multiple vaccines, the %O-Ag dep Ab trended with vaccine efficacy. Among S4ΔguaBA-vaccinated Rbs, the %O-Ag dep Ab in pre-challenge plasma was significantly higher in survivors than in non-survivors; a cut-off of >70% O-Ag dep Ab predicted survival with high sensitivity and specificity. Finally, we found this COP in 80% of LVS-vaccinated Hu plasma samples as expected for a vaccine with 80% Hu efficacy. Collectively, the %O-Ag dep Ab response is a bona fide COP for S4ΔguaBA-vaccinated Rb and holds significant promise for guiding vaccine trials with higher animals.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17606
- Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
- Authors: O'Malley KJ, Bowling JD, Stinson E, Cole KS, Mann BJ, Namjoshi P, Hazlett KRO, Barry EM, Reed DS
- Issue date: 2018
- An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
- Authors: Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW
- Issue date: 2008 Sep 26
- A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
- Authors: De Pascalis R, Hahn A, Brook HM, Ryden P, Donart N, Mittereder L, Frey B, Wu TH, Elkins KL
- Issue date: 2018
- Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.
- Authors: Reed DS, Smith LP, Cole KS, Santiago AE, Mann BJ, Barry EM
- Issue date: 2014 May
- Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
- Authors: De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL
- Issue date: 2014 Apr 8